Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

'Non-criteria' neurologic manifestations of antiphospholipid syndrome: A hidden kingdom to be discovered.
How do Australians living with MS experience oral health and accessing dental care? A focus group study.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS - YES.
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.
[Endogenous retroviruses are associated with autoimmune diseases].
Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA Sequencing.
Is Season of Birth Important for Multiple Sclerosis Risk?
Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups.
Stem Cells Therapy in Multiple Sclerosis - A New Hope for Progressive Forms.
Ubiquitination of RORγt at Lysine 446 Limits Th17 Differentiation by Controlling Coactivator Recruitment.
Ionotropic glutamate receptor expression in human white matter.
Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis.
Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination.
Repeated mild traumatic brain injury: potential mechanisms of damage.
Report: Stem cell applications in neurological practice, an expert group consensus appraisal.
Cognitive impairment in MS: rehabilitation approaches.
Progesterone treatment modulates mRNA OF neurosteroidogenic enzymes in a murine model of multiple sclerosis.
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment.
Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality.
Early effect of dalfampridine in patients with MS: A multi-instrumental approach to better investigate responsiveness.

Pages